Outlook Therapeutics, Inc. (OTLK) NASDAQ

0.41

-0.0215(-4.95%)

Updated at February 20 04:00PM

Currency In USD

Valuation

Market Cap36.88M
Enterprise Value-7.84T
P/E Ratio-0.24
PEG Ratio0
Price/Sales Ratio82.62
Price/Book Ratio-0
Enterprise/Revenue1.13M
Enterprise/EBITDA-3,854.95

Fiscal Year

Fiscal YearSeptember 30, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-500.45
Operating Margin-286.76

Management Effectiveness

Return On Assets-0
Return On Equity0

Income Statement

Revenue1.41M
Revenue/Share0
Gross Profit657,205
EBITDA-63.58M
Net Income-62.42M
Diluted EPS-1.79

Balance Sheet

Total Cash8.68M
Total Cash/Share0.14
Total Debt233.11B
Total Debt/Equity-0.01
Current Ratio0
Book Value Per Share-640,303.38

Price History

52-Week Change-73.52
52-Week High3.39
52-Week Low0.38
Moving Average 50 Days1.1
Moving Average 200 Days1.5

Statistics

Average Volume6.14M
Shares Outstanding41.11M
% Held by Institutions11.33

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateMarch 14, 2024